Most Read Articles
2 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.

The Heart Failure Frequent Flyer Programme changes the trajectories of patients with chronic heart failure

24 Aug 2020
Chronic heart failure (CHF) is a significant public health concern, affecting at least 26 million individuals worldwide.1 In this case study, Professor Dr Chee Kok Han and Dr Nur Asyikin share their clinical experience running the Heart Failure Frequent Flyer Programme – an initiative between HTAR and UMMC. The Programme enrols CHF patients who had been hospitalised for HF at least twice over the past 12 months and diagnosed with New York Heart Association (NYHA) class II–IV.2

CHF is a frequent cause of hospitalisation at HTAR – a total of 1,140 patients were admitted for CHF between April 2017 and April 2018, with a mean length of stay of 8.2 days. In addition to causing high mortality, hospitalisation for HF (HHF) also places a significant financial burden on patients and the healthcare system. Notably, frequent hospitalisation strongly predicts mortality among patients with CHF – approximately 93% of CHF patients treated at HTAR have recent histories of recurrent admission to the hospital for worsening HF.

The Heart Failure Frequent Flyer Programme was set up with the principal goal of reducing hospitalisation in patients with CHF to improve functional status, quality of life (QoL) and cost of care.The Programme is conducted via a holistic and multidisciplinary approach, incorporating a dedicated HF team (consisting of clinical specialists, clinical pharmacists, HF nurses, dietitian and cardiac rehabilitation team), pharmacist-led patient counselling sessions, as well as nurse-led telemonitoring and SOS walk-in services.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.